Management of Secondary Polycythemia in Smokers

Initial Assessment and Diagnosis

Smoking directly contributes to elevated hemoglobin through carbon monoxide exposure leading to increased carboxyhemoglobin formation, in a female smoker with a hemoglobin of 19 g/dL 1, 2

The American College of Cardiology recommends immediate smoking cessation counseling using the 5 A's approach (Ask, Advise, Assess, Assist, Arrange) in smokers with elevated hemoglobin 3
Pharmacotherapy options such as nicotine replacement therapy, bupropion, and varenicline should be offered to smokers with elevated hemoglobin 3, 4
Smoking cessation can normalize hemoglobin levels within weeks to months and significantly reduces cardiovascular risk in smokers with elevated hemoglobin 5

Arterial blood gas should be performed to assess oxygen saturation and rule out hypoxemia in smokers with elevated hemoglobin 1
Echocardiogram should be performed to assess for cardiac causes of secondary polycythemia in smokers with elevated hemoglobin 6

The American College of Cardiology recommends smoking cessation as the cornerstone of treatment for secondary polycythemia in smokers 3, 4
Underlying cardiopulmonary disease should be evaluated and treated to reduce hypoxemia in smokers with elevated hemoglobin 6
Blood pressure should be monitored closely, as hypertension often coexists and compounds cardiovascular risk in smokers with elevated hemoglobin 6

Low-dose aspirin should be offered to reduce thrombotic risk in smokers with elevated hemoglobin if no contraindications exist, as recommended by the Journal of the American Geriatrics Society 7
Target blood pressure should be <140/80 mmHg to further reduce cardiovascular risk in smokers with elevated hemoglobin 7

Continued smoking cessation support with regular follow-up visits is essential for smokers with elevated hemoglobin, as recommended by the American College of Cardiology 3